The phrase “WHO-GMP Certified” appears on almost every pharmaceutical company’s marketing material — but few pharma brand owners or procurement managers truly understand what this certification guarantees, how it is audited, and why it matters specifically when choosing a third-party contract manufacturer in India.
This article breaks down WHO-GMP certification for pharmaceutical manufacturing in India — from its legal basis to what it means in practice for batch quality, documentation, and your product liability as a brand owner.
What is WHO-GMP Certification?
World Health Organization Good Manufacturing Practice (WHO-GMP) is a set of internationally recognised quality standards that govern the conditions under which pharmaceutical products are manufactured, tested, and released.
In India, WHO-GMP is implemented through Schedule M of the Drugs and Cosmetics Act, 1940. A manufacturing facility certified under WHO-GMP (Schedule M) must demonstrate:
- Validated manufacturing processes — every batch is produced by a documented, reproducible procedure
- Qualified personnel — production staff, QC analysts, and QA managers with defined competency requirements
- Controlled environments — temperature, humidity, and cross-contamination prevention across all manufacturing areas
- Complete batch documentation — batch manufacturing records (BMRs), analytical test reports (ATRs), and stability data
- Robust recall systems — ability to trace and retrieve any batch distributed in the market
WHO-GMP certification is not a one-time achievement. It requires annual internal audits and periodic state drug authority inspections to maintain the license. A facility that passes a single inspection but allows standards to lapse will lose certification — and with it, the legal authority to manufacture.
Why It Matters Specifically for Third-Party Manufacturing
When you contract a third-party manufacturer to produce your branded pharmaceutical product, your name appears on the carton. The batch is yours. So is the liability if quality fails.
This is the most critical distinction that brand owners often overlook:
| Risk Area | WHO-GMP Certified Manufacturer | Uncertified Manufacturer |
|---|---|---|
| Regulatory liability | Shared and documented | Yours alone |
| Batch recall process | Defined, auditable | Undefined |
| DCGI license validity | Verified, renewable | Potentially lapsing |
| Export eligibility | COA accepted internationally | COA rarely accepted |
| Quality documentation | Full BMR + COA available | Often incomplete |
A WHO-GMP certified contract manufacturer gives your brand regulatory cover — your product’s manufacturing has been independently verified by the state drug authority.
WHO-GMP vs ISO 9001 — Are They the Same?
A common misconception is that ISO 9001:2015 certification and WHO-GMP are equivalent. They are not — though both are important.
ISO 9001:2015 is a general quality management system standard applicable to any industry. It ensures a company has documented processes, customer focus, and continuous improvement. However, it does not specifically govern pharmaceutical manufacturing conditions.
WHO-GMP (Schedule M) is pharma-specific. It governs:
- Physical facility requirements (room classifications, HVAC, airlocks)
- Raw material testing and vendor qualification
- In-process quality controls during manufacturing
- Microbiological testing for sterile and liquid products
- Stability and shelf-life validation
The Correct Position for a B2B Pharma Buyer
Both certifications together provide the strongest assurance. ISO 9001:2015 ensures a systemic quality culture; WHO-GMP ensures the physical and procedural environment meets pharmaceutical grade requirements.
How Saar Biotech Maintains WHO-GMP Compliance
Our manufacturing facility at EPIP, Phase-1, Baddi, Himachal Pradesh operates under a current WHO-GMP license, Schedule M compliant, with the following active controls:
Dedicated Segregated Manufacturing Lines
Beta-Lactam (penicillin-class antibiotics) and Non-Beta-Lactam products are manufactured in physically separate, dedicated blocks. This is not just best practice — it is a WHO-GMP requirement for preventing cross-contamination that could cause life-threatening allergic reactions.
Environmental Monitoring
All critical areas — filling rooms, mixing areas, and packaging lines — are monitored for:
- Airborne particulate count (ISO 8 / Class D cleanroom standards)
- Microbial contamination (settle plates, contact plates)
- Temperature and humidity (continuous chart recorders)
Batch Documentation
Every batch manufactured at Saar Biotech generates a complete Batch Manufacturing Record (BMR) and Batch Packaging Record (BPR). These are stored for the legally mandated period and are available to clients on request as part of the complete testing reports and COA.
View manufacturing details for azithromycin-oral-solution
Regulatory Requirements for Starting a Pharma Brand Using Contract Manufacturing
If you are a pharma entrepreneur or established brand looking to launch a new product through a contract manufacturer, here is the regulatory pathway:
- Drug Master File (DMF) — filed by the manufacturer for the formulation
- Form 25 / 25A — your brand’s drug manufacturing permission (state-level)
- NOC from contract manufacturer — permission to manufacture on behalf of your brand
- DCGI approval — for new drug molecules not previously approved in India
- Labelling and artwork approval — reviewed against Drugs & Cosmetics Act Schedule H/H1 requirements
Saar Biotech’s regulatory team assists with complete testing reports, state drug license NOCs, and DCGI filing support — so brand owners can focus on distribution rather than paperwork.
Key Questions to Ask Your Contract Manufacturer
Before signing a manufacturing agreement, ask these — and insist on documented answers:
- Is your WHO-GMP license current and state drug authority verified? Ask for the license number and expiry date.
- Do you have dedicated lines or shared lines for my product category? Shared lines require validated changeover cleaning procedures.
- Can I audit your facility before the first batch? Any credible manufacturer welcomes this.
- What is your batch rejection rate and what happens to rejected batches? A manufacturer with zero rejections is not doing rigorous QC — it may mean they are passing non-conforming batches.
- Do you provide a Certificate of Analysis (COA) for every batch? The COA should include all pharmacopoeial tests — assay, dissolution, uniformity of content, microbiological limits.
Conclusion
WHO-GMP certification is the floor — not the ceiling — of pharmaceutical quality. For third-party pharma manufacturing in India, it means your product is produced in a legally compliant, regularly inspected, documented facility where quality failures can be traced, investigated, and corrected.
At Saar Biotech, our WHO-GMP and ISO 9001:2015 certified plant in Baddi has manufactured for 2,000+ pharma brands across India. Our mandate is simple: every batch that leaves our facility carries the same quality assurance as if it were manufactured by the brand itself.
If you are evaluating a contract manufacturing partnership, we invite you to schedule a facility visit or request a product-specific quote.
Frequently Asked Questions
What does WHO-GMP certification mean for third-party manufacturing?
WHO-GMP certification ensures that the third-party manufacturer adheres to strict international quality standards, covering facility design, raw material testing, production processes, and documentation. This guarantees the safety and efficacy of the final product and provides your brand with regulatory cover — your product's manufacturing has been independently verified by the state drug authority.
Is ISO 9001 the same as WHO-GMP?
No. ISO 9001 is a general quality management system standard applicable to any industry, whereas WHO-GMP (Schedule M in India) specifically dictates pharmaceutical manufacturing conditions, including HVAC systems, microbial limits, segregated manufacturing lines for beta-lactam products, and batch documentation requirements. The strongest assurance comes from a facility holding both certifications.
Can I inspect the Saar Biotech facility before signing a contract?
Absolutely. We welcome independent audits by our B2B partners and brand owners to verify our WHO-GMP compliance, documentation practices, environmental monitoring records, and manufacturing standards. We can arrange facility visits for qualified pharma professionals at mutually convenient times.
How often is WHO-GMP compliance verified?
In India, state drug authorities conduct inspections at intervals defined by the state licensing authority — typically every 2–3 years for renewal, but spot inspections can occur at any time. At Saar Biotech, we conduct quarterly internal audits and an annual management review against WHO-GMP standards, independent of external inspections.
What happens if a batch fails QC testing at a WHO-GMP facility?
A credible WHO-GMP manufacturer has a documented Out-of-Specification (OOS) investigation procedure. The batch is quarantined immediately. A laboratory investigation rules out testing errors. If the failure is confirmed, the batch is rejected and destroyed — it is never released, blended with other batches, or reworked without full revalidation. A rejection rate of exactly zero should raise red flags, not confidence.
For regulatory assistance or to schedule a facility visit at Saar Biotech’s Baddi plant, contact us at quotation@saarbiotech.com or call +91 9357690454.